Post-insult exposure to (±) kavain potentiates N-methyl-D-aspartate toxicity in the developing hippocampus

Brain Research

Volumn 945, Issue 1, 2002, Pages 106-113

  Mulholland, Patrick J ^a   Prendergast, Mark A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Kava kava; Kavapyrone; Neurotoxicity; NMDA; Piper methysticum

Indexed keywords

KAWAIN; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; DRUG EXPOSURE; EXPLANT; HIPPOCAMPUS; MALE; NERVE CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; DRUG SYNERGISM; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; MALE; N-METHYLASPARTATE; NEUROTOXINS; PYRONES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037178665     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02745-2     Document Type: Article

References (29)

1. Herbal medicines and perioperative care
2. Effects of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats
3. In vivo effects of the kavapyrones (+)-dihydromethysticin and (±)-kavain on dopamine, 3,4-dihydrophenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions
4. Influence of genuine kavapyrone enantiomers on the GABA-A binding site
5. The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenyl-pyridinium (MPP+)
6. Excitotoxic cell death
7. Interaction of various Piper methysticum cultivars with CNS receptors in vitro
8. Laminar difference in GABA uptake and GAT0-1 expression in rat CA1
9. In vivo microdialysis study of (±)-kavain on veratridine-induced glutamate release
10. (±)-Kavain inhibits veratridine-activated voltage-dependent Na(+)-channels in synaptosomes prepared from rat cerebral cortex
11. Synaptic reorganization in explanted cultures of rat hippocampus
12. The function of kava in modern samoan culture
13. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome
14. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain
15. Uptake into mouse brain of four compounds present in the psychoactive beverage kava
16. Hippocampal CA1 lacunosum-moleculare interneurons: Modulation of monosynaptic GABAergic IPSCs by presynaptic GABAB receptors
17. Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks
18. Distribution of [3H]MK-801, [3H]AMPA and [3H]Kainate binding sites in rat hippocampal long-term slice cultures isolated from external afferents
19. Pharmacology of kava
20. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
21. Chronic nicotine exposure reduces N-methyl-D-aspartate receptor-mediated damage in the hippocampus without altering calcium accumulation or extrusion: Evidence of calbindin-D 28K overexpression
22. Kava-kava extract in anxiety disorders: An outpatients observational study
23. Effects of (+/-)-kavain on voltage-activated inward currents of dorsal root ganglion cells from neonatal rats
24. Neuroprotective effects of (±)-kavain in the MPTP mouse model of Parkinson's disease
25. Kava, an overview
26. A simple method for organotypic cultures of nervous tissue
27. Effects of gamma-aminobutyric acid (GABA) receptor agonists on the neurotoxicity and anticonvulsant activity of barbiturates in mice
28. Kava-kava extract WS 1490 versus placebo in anxiety disorders - A randomized placebo-controlled 25-week outpatient trial
29. Effects of kavain and dihydromethysticin on field potential changes in the hippocampus